(NOMD) Nomad Foods - Ratings and Ratios
Fish, Vegetables, Poultry, Meals, Desserts
Dividends
| Dividend Yield | 5.51% |
| Yield on Cost 5y | 2.97% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 100.0% |
| Payout Ratio | 41.7% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 24.9% |
| Value at Risk 5%th | 38.9% |
| Relative Tail Risk | -5.05% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.25 |
| Alpha | -32.79 |
| CAGR/Max DD | -0.18 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.494 |
| Beta | 0.157 |
| Beta Downside | 0.097 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.64% |
| Mean DD | 12.62% |
| Median DD | 10.04% |
Description: NOMD Nomad Foods November 09, 2025
Nomad Foods Ltd (NYSE:NOMD) manufactures, markets, and distributes a broad portfolio of frozen foods-including fish, vegetables, poultry, ready-to-cook meals, ice-cream, soups, pizzas and meat-alternatives-under well-known brands such as Birds Eye, Findus, Aunt Bessie’s and iglo. The company sells primarily to supermarkets and food-retail chains across the United Kingdom and a growing set of international markets, leveraging its European footprint established since its 2014 founding in Woking, UK.
Key performance indicators from the most recent FY2023 filing show revenue of approximately £2.1 bn, an adjusted EBITDA margin near 8 %, and free cash flow of about £150 m, reflecting the relative resilience of frozen foods to inflationary pressure. The sector’s growth is driven by consumer demand for convenient, long-shelf-life products and by supply-chain efficiencies that keep input costs stable; Nomad’s acquisition of the Findus brand in 2021 expanded its market share in continental Europe, positioning it to benefit from a projected 3-4 % CAGR in the global frozen-food market through 2028.
If you want a data-rich, side-by-side comparison of Nomad’s valuation metrics and peer benchmarks, a quick look at the company’s profile on ValueRay can provide the deeper quantitative context you need.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (198.8m TTM) > 0 and > 6% of Revenue (6% = 183.2m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 0.96pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 0.80% (prev 6.68%; Δ -5.88pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 400.7m > Net Income 198.8m (YES >=105%, WARN >=100%) |
| Net Debt (1.91b) to EBITDA (469.0m) ratio: 4.08 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.02 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (147.7m) change vs 12m ago -9.45% (target <= -2.0% for YES) |
| Gross Margin 27.88% (prev 29.33%; Δ -1.45pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 47.73% (prev 47.33%; Δ 0.39pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.45 (EBITDA TTM 469.0m / Interest Expense TTM 148.5m) >= 6 (WARN >= 3) |
Altman Z'' 1.78
| (A) 0.00 = (Total Current Assets 1.14b - Total Current Liabilities 1.12b) / Total Assets 6.31b |
| (B) 0.20 = Retained Earnings (Balance) 1.28b / Total Assets 6.31b |
| (C) 0.06 = EBIT TTM 363.6m / Avg Total Assets 6.40b |
| (D) 0.68 = Book Value of Equity 2.54b / Total Liabilities 3.76b |
| Total Rating: 1.78 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 66.08
| 1. Piotroski 5.0pt |
| 2. FCF Yield 9.20% |
| 3. FCF Margin 10.37% |
| 4. Debt/Equity 0.82 |
| 5. Debt/Ebitda 4.08 |
| 6. ROIC - WACC (= 2.87)% |
| 7. RoE 7.65% |
| 8. Rev. Trend 56.82% |
| 9. EPS Trend 14.61% |
What is the price of NOMD shares?
Over the past week, the price has changed by +2.66%, over one month by +1.81%, over three months by -11.35% and over the past year by -27.30%.
Is NOMD a buy, sell or hold?
- Strong Buy: 5
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the NOMD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 17 | 37.4% |
| Analysts Target Price | 17 | 37.4% |
| ValueRay Target Price | 12.1 | -2.2% |
NOMD Fundamental Data Overview December 10, 2025
P/E Trailing = 7.98
P/E Forward = 11.1359
P/S = 0.5891
P/B = 0.5932
P/EG = 1.38
Beta = 0.714
Revenue TTM = 3.05b EUR
EBIT TTM = 363.6m EUR
EBITDA TTM = 469.0m EUR
Long Term Debt = 2.08b EUR (from longTermDebt, last quarter)
Short Term Debt = 28.5m EUR (from shortTermDebt, last quarter)
Debt = 2.11b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.91b EUR (from netDebt column, last quarter)
Enterprise Value = 3.44b EUR (1.53b + Debt 2.11b - CCE 193.6m)
Interest Coverage Ratio = 2.45 (Ebit TTM 363.6m / Interest Expense TTM 148.5m)
FCF Yield = 9.20% (FCF TTM 316.7m / Enterprise Value 3.44b)
FCF Margin = 10.37% (FCF TTM 316.7m / Revenue TTM 3.05b)
Net Margin = 6.51% (Net Income TTM 198.8m / Revenue TTM 3.05b)
Gross Margin = 27.88% ((Revenue TTM 3.05b - Cost of Revenue TTM 2.20b) / Revenue TTM)
Gross Margin QoQ = 27.57% (prev 27.62%)
Tobins Q-Ratio = 0.55 (Enterprise Value 3.44b / Total Assets 6.31b)
Interest Expense / Debt = 1.42% (Interest Expense 29.8m / Debt 2.11b)
Taxrate = 18.18% (12.8m / 70.4m)
NOPAT = 297.5m (EBIT 363.6m * (1 - 18.18%))
Current Ratio = 1.02 (Total Current Assets 1.14b / Total Current Liabilities 1.12b)
Debt / Equity = 0.82 (Debt 2.11b / totalStockholderEquity, last quarter 2.55b)
Debt / EBITDA = 4.08 (Net Debt 1.91b / EBITDA 469.0m)
Debt / FCF = 6.04 (Net Debt 1.91b / FCF TTM 316.7m)
Total Stockholder Equity = 2.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.15% (Net Income 198.8m / Total Assets 6.31b)
RoE = 7.65% (Net Income TTM 198.8m / Total Stockholder Equity 2.60b)
RoCE = 7.78% (EBIT 363.6m / Capital Employed (Equity 2.60b + L.T.Debt 2.08b))
RoIC = 6.32% (NOPAT 297.5m / Invested Capital 4.71b)
WACC = 3.45% (E(1.53b)/V(3.64b) * Re(6.59%) + D(2.11b)/V(3.64b) * Rd(1.42%) * (1-Tc(0.18)))
Discount Rate = 6.59% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -5.22%
[DCF Debug] Terminal Value 79.89% ; FCFE base≈295.2m ; Y1≈331.5m ; Y5≈443.7m
Fair Price DCF = 52.46 (DCF Value 7.69b / Shares Outstanding 146.6m; 5y FCF grow 14.28% → 3.0% )
EPS Correlation: 14.61 | EPS CAGR: 11.12% | SUE: 0.84 | # QB: 0
Revenue Correlation: 56.82 | Revenue CAGR: 1.79% | SUE: -0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.37 | Chg30d=+0.004 | Revisions Net=+0 | Analysts=5
EPS next Year (2026-12-31): EPS=1.73 | Chg30d=-0.043 | Revisions Net=-1 | Growth EPS=+3.9% | Growth Revenue=+1.4%
Additional Sources for NOMD Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle